- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To evaluate the efficacy of allopurinol therapy for improving cardiovascular outcomes in patients at high and very high cardiovascular risk
- Number of participants enrolled: Publication not available
- Study enrolling from
- Study includes follow-up for 5 years
Study Data
- Adults
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Allopurinol
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to